Fusion proteins of human gonadotropins and gonadotropin-receptor complexes

Indian Journal of Experimental Biology

Volumn 40, Issue 4, 2002, Pages 415-423

  Puett, David ^a   Narayan, Prema ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELLS; MEDICINE; MUTAGENESIS; PROTEINS;

HUMAN GONADOTROPHINS;

HORMONES;

CHORIONIC GONADOTROPIN; CYCLIC AMP; FOLLITROPIN; FOLLITROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GONADOTROPIN RECEPTOR; HYBRID PROTEIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR;

CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; ENZYME SUBUNIT; GENETIC COMPLEMENTATION; GENETIC TRANSFECTION; GLYCOSYLATION; SITE DIRECTED MUTAGENESIS;

EID: 0036218433     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. The glycoprotein hormones: Recent studies of structure-function relationships
2. Gonadotropin receptors
3. Molecular biology of the pituitary gonadotropins
4. The gonadotropin genes: Evolution of distinct mechanisms for hormonal control
5. Isolation and characterization of human pituitary chorionic gonadotropin
6. The lutropin/choriogonadotropin receptor 4 years later
7. The luteinizing hormone receptor
8. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology
9. Biosynthesis of a biologically active single peptide chain containing the human common α and chorionic gonadotropin β subunits in tandem
10. Functional expression of yoked human chorionic gonadotropin in baculovirus-infected insect cells
11. Expression of biologically active fusion genes encoding the common α subunit and the follicle-stimulating hormone β subunit
12. Converting heterodimeric gonadotropins to genetically linked single chains
13. Design of stable biologically active recombinant lutropin analogs
14. Evaluation of subunit truncation and the nature of the spacer for single chain human gonadotropins
15. Expression of a bioactive, single-chain choriogonadotropin in Dictyostelium discoideum
16. The tie that binds: Design of biologically active single-chain human chorionic gonadotropin's and a gonadotropin-receptor complex using protein engineering
17. The position of the α and β subunits in a single chain variant of human chorionic gondadotropin affects the heterodimeric interaction of the subunits and receptor-binding epitopes
18. A biologically active single chain human chorionic gonadotropin, analog with altered receptor binding properties
19. Biological activity of single chain chorionic gonadotropin, hCGαβ, is decreased upon deletion of five carboxyl terminal amino acid residues of the α subunit without affecting its receptor binding
20. Genetic engineering of single-chain gonadotropins and hormone-receptor fusion proteins
21. The biologic action of single-chain choriogonadotropin is not dependent on the individual disulfide bonds of the β subunit
22. Cystine knot of the gonadotropin α subunit is critical for intracellular behavior but not for in vitro biological activity
23. The biological action of choriogonadotropin is not dependent on the complete native quaternary interactions between the subunits
24. Towards minimized gonadotropins with full bioactivity
25. Synthesis of multi-subunit domain gonadotropin complexes: A model for α/β heterodimer formation
26. Genetic fusion of an α-subunit gene to the follicle-stimulating hormone and chorionic gonadotropin-β subunit genes: Production of a bifunctional protein
27. Deglycosylation of a bifunctional lutropin-follitropin agonist reduced its follitropin activity more than its lutropin activity
28. Dual activity gonadotropin analogs with linked subunits of the peripheral loops
29. Structure based design and protein engineering of intersubunit disulfide bonds in gonadotropins
30. Partially deglycosylated human choriogonadotropin, stabilized by intersubunit disulfide bonds, shows full bioactivity
31. Protein engineering of a novel constitutively active hormone-receptor complex
32. The effects of modification of the COOH-terminal regions of bovine thyrotropin and its subunits
33. Studies of the specific role of the subunits of choriogonadotropin for biological, immunological and physical properties of the hormone
34. Biologically active covalently cross-linked glycoprotein hormones and the effects of modification of the COOH-terminal region of their α-subunits
35. Conversion of lysine 91 to methionine or glutamic acid in human choriogonadotropin α results in the loss of cAMP inducibility
36. The carboxy-terminal region of the glycoprotein hormone α-subunit: Contributions to receptor binding and signalling in human chorionic gonadotropin
37. COOH-terminal amino acids of the α subunit play common and different roles in human choriogonadotropin and follitropin
38. 90 of the α-subunit are crucial for receptor-binding and hormone action of follicle-stimulating hormone (FSH) and play hormone-specific roles in FSH and human chorionic gonadotropin
39. Against the dogma: Recombinant free alpha-subunit analogs with biological activity: Implications for glycoprotein hormone minimization, evolution and hormone-receptor interaction
40. Expression and characterization of recombinant β-subunit of hCG homodimer
41. Crystal structure of human chorionic gonadotropin
42. Structure of human chorionic gonadotropin at 2.6A resolution from MAD analysis of the selenomethionyl protein
43. Site-directed mutagenesis defines a domain in the gonadotropin α-subunit required for assembly with the chorionic gonadotropin β-subunit
44. 44 in the human gonadotropin α-subunit
45. A region in the human glycoprotein hormone α-subunit important in holoprotein formation and receptor binding
46. Engineering human glycoprotein hormone superactive analogues
47. Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction
48. Molecular genetic, biomedical, and clinical implications of gonadotropin receptor mutations
49. Disorders caused by mutations of the lutropin/choriogonadotropin receptor gene
50. Activation of the human receptors for FSH and TSH by hCG. The use of fusion proteins to study weak ligand-noncognate receptor interactions